Play

If you’re at risk to develop ovarian cancer, does it make sense to remove your fallopian tubes, which bridge the ovaries and the uterus? Perhaps, according to William Nelson, director of the Kimmel Cancer Center at Johns Hopkins. Nelson: I …

How can we reduce the toll of ovarian cancer? Elizabeth Tracey reports Read more »

Play

Ovarian cancer has a very poor prognosis, often because it’s so advanced when it’s found. A growing trend is underway to remove the fallopian tubes, which bridge the uterus and the ovaries, to stave off the development of ovarian cancer. …

Should you remove fallopian tubes to reduce the risk of ovarian cancer? Elizabeth Tracey reports Read more »

Play

Moderna, the maker of Covid vaccines, is now reporting success with a vaccine for the skin cancer melanoma. Johns Hopkins Kimmel Cancer Center director William Nelson says these are made for individual patients using markers that are specific for their …

Makers of Covid vaccines are achieving success with cancer vaccines, Elizabeth Tracey reports Read more »

Play

Women receiving radiation therapy for breast cancer can now have fewer treatments and may also be able to change the interval, a study presented at the San Antonio Breast Cancer Symposium shows. Kimmel Cancer Center director William Nelson at Johns …

Can radiation therapy be made less onerous? Elizabeth Tracey reports Read more »

Play

Young women with breast cancer often state they’d like to have children at some point, yet after they’re treated their maintenance therapy may pose barriers. Now a study presented at the San Antonio Breast Cancer Symposium shows that pausing therapy …

Young women with breast cancer may be able to safely pause treatment to have a child, Elizabeth Tracey reports Read more »

Play

Tumor infiltrating lymphocytes, known as TILS, allowed people with advanced melanoma, a serious type of skin cancer, to live longer than those who received an antibody alone, a recent study showed. Kimmel Cancer Center director William Nelson at Johns Hopkins …

A type of individualized T cell helps people with advanced melanoma, Elizabeth Tracey reports Read more »